Results 1 to 10 of about 4,751,169 (290)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events [PDF]

Scientific Reports, 2016
AbstractIncreasing evidence has shown that sex differences exist in Adverse Drug Events (ADEs). Identifying those sex differences in ADEs could reduce the experience of ADEs for patients and could be conducive to the development of personalized medicine.
Yue Yu, Jun Chen, Dingcheng Li, Liwei Wang, Wei Wang, Hongfang Liu   +5 more
semanticscholar   +3 more sources

A Standardized Dataset of a Spontaneous Adverse Event Reporting System

Healthcare, 2022
One of the largest spontaneous adverse events reporting databases in the world is the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). Unfortunately, researchers face many obstacles in analyzing data from the FAERS database. One
M. A. Khaleel, A. Khan, S. Ghadzi, A. Adnan, Qasem M A Abdallah   +4 more
semanticscholar   +1 more source

Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019.

Journal of the American Medical Association (JAMA), 2022
Importance Patient safety is a US national priority, yet lacks a comprehensive assessment of progress over the past decade. Objective To determine the change in the rate of adverse events in hospitalized patients.
Noel E. Eldridge, Yun Wang, M. Metersky, Sheila Eckenrode, Jasie Mathew, N. Sonnenfeld, Jade K Perdue-Puli, David R. Hunt, P. J. Brady, Paul McGann, Erin N. Grace, David Rodrick, E. Drye, H. Krumholz   +13 more
semanticscholar   +1 more source

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States

JAMA Network Open, 2021
Key Points Question Does public sentiment of human papillomavirus (HPV) vaccine safety align with spontaneous HPV vaccine adverse event reporting data? Findings This cross-sectional analysis of the 2015 to 2018 National Immunization Survey indicates a 79.
K. Sonawane, Yueh-Yun Lin, Haluk Damgacioglu, Yenan Zhu, Maria E Fernandez, J. Montealegre, C. G. Cazaban, Ruosha Li, D. Lairson, Ying Lin, A. Giuliano, A. Deshmukh   +11 more
semanticscholar   +1 more source

Adverse events [PDF]

American Journal of Orthodontics and Dentofacial Orthopedics, 2017
Any medical intervention generates modifications in the homeostasis of the treated organism. The effect in most cases is not apparent at the clinical level; when manifested, it may be inherent to the expected therapeutic action or associate as a side effect expressed in a multiplicity of epiphenomena with different physiognomy and capacity of altering ...
openaire   +4 more sources

Adverse event reporting in intervention research for young autistic children

Autism, 2020
Our team examined 150 reports on group-design, non-pharmacological interventions for young autistic children, to determine the prevalence of adverse event reporting.
K. Bottema‐Beutel, S. Crowley, Micheal Sandbank, Tiffany G. Woynaroski   +3 more
semanticscholar   +1 more source

Adverse Events in NMOSD Therapy [PDF]

International Journal of Molecular Sciences, 2022
Neuromyelitis optica spectrum disorders (NMOSD) are rare neurologic autoimmune diseases that have a poor prognosis if left untreated. For many years, generic oral immunosuppressants and repurposed monoclonal antibodies that target the interleukin-6 pathway or B cells were the mainstays of drug treatment.
Katrin Giglhuber, Achim Berthele
openaire   +2 more sources

Gastrointestinal adverse events of immunotherapy

BJR|Open, 2021
Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free survival, but the enhancement of normal immunity can ...
Cappello, Giovanni, Molea, Francesca, Campanella, Delia, Galioto, Francesca, Russo, Filippo, Regge, Daniele   +5 more
openaire   +4 more sources

Adverse events of raltegravir and dolutegravir [PDF]

AIDS, 2017
OBJECTIVE To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN Prospective cohort study. METHODS All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who initiated raltegravir or dolutegravir between 2006 and ...
Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel   +8 more
openaire   +6 more sources

Errors and adverse events in otolaryngology [PDF]

Current Opinion in Otolaryngology & Head & Neck Surgery, 2006
The study of errors in medicine has proliferated in the past few years. This spark was ignited by the Institute of Medicine's report in 2000, titled 'To Err is Human'. Studies of errors have been performed in both medical and surgical specialties. Surgical skill and technology has proliferated over the last century to such an extent that outcomes will ...
Rahul K. Shah, Gerald B. Healy, David W. Roberson   +2 more
openaire   +4 more sources